[
  {
    "ts": null,
    "headline": "2 Surefire Dividend Stocks That Could Pay You for Life",
    "summary": "Dividend investing is an excellent strategy for (at least) two reasons.  Here are two companies that can pull it off: Amgen (NASDAQ: AMGN) and Coca-Cola (NYSE: KO).  Amgen paid its first dividend in 2011.",
    "url": "https://finnhub.io/api/news?id=8e370c6a2f22875278a1ed6eab738cfee02dc971e53047d1c34f55d8d9824326",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1743171300,
      "headline": "2 Surefire Dividend Stocks That Could Pay You for Life",
      "id": 133523787,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "AMGN",
      "source": "Yahoo",
      "summary": "Dividend investing is an excellent strategy for (at least) two reasons.  Here are two companies that can pull it off: Amgen (NASDAQ: AMGN) and Coca-Cola (NYSE: KO).  Amgen paid its first dividend in 2011.",
      "url": "https://finnhub.io/api/news?id=8e370c6a2f22875278a1ed6eab738cfee02dc971e53047d1c34f55d8d9824326"
    }
  },
  {
    "ts": null,
    "headline": "2 Large-Cap Stocks with Solid Fundamentals and 1 to Turn Down",
    "summary": "Large-cap stocks are known for their staying power and ability to weather market storms better than smaller competitors. However, their sheer size makes it more challenging to maintain high growth rates as they’ve already captured significant portions of their markets.",
    "url": "https://finnhub.io/api/news?id=af5cdd1563fab45422fe7b0e9ed0ad8f01517b306d766fc600c79ce100018362",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1743166877,
      "headline": "2 Large-Cap Stocks with Solid Fundamentals and 1 to Turn Down",
      "id": 133508614,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "AMGN",
      "source": "Yahoo",
      "summary": "Large-cap stocks are known for their staying power and ability to weather market storms better than smaller competitors. However, their sheer size makes it more challenging to maintain high growth rates as they’ve already captured significant portions of their markets.",
      "url": "https://finnhub.io/api/news?id=af5cdd1563fab45422fe7b0e9ed0ad8f01517b306d766fc600c79ce100018362"
    }
  },
  {
    "ts": null,
    "headline": "Amgen Inc. (AMGN) is Attracting Investor Attention: Here is What You Should Know",
    "summary": "Zacks.com users have recently been watching Amgen (AMGN) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.",
    "url": "https://finnhub.io/api/news?id=976d484c3304ea70d9e10423bd96d577652e493050eed547c901efe7f79c11d8",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1743166808,
      "headline": "Amgen Inc. (AMGN) is Attracting Investor Attention: Here is What You Should Know",
      "id": 133523829,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "AMGN",
      "source": "Yahoo",
      "summary": "Zacks.com users have recently been watching Amgen (AMGN) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.",
      "url": "https://finnhub.io/api/news?id=976d484c3304ea70d9e10423bd96d577652e493050eed547c901efe7f79c11d8"
    }
  },
  {
    "ts": null,
    "headline": "Which Dow Jones Stock Is Cheaper, Amgen or Merck?",
    "summary": "Within that group, biotechnology giant Amgen (NASDAQ: AMGN) has been the best-performing stock in 2025, returning an impressive 21% year to date.  Meanwhile, shares of its pharmaceutical rival Merck (NYSE: MRK) have lagged, down 8% in the same period.  Amgen shareholders are celebrating, but have you wondered which stock is cheaper right now?",
    "url": "https://finnhub.io/api/news?id=2098633fa61e26ac514cdfd5c24d0756e5917dc5dbeb8609a8a0266e0f23e750",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1743165000,
      "headline": "Which Dow Jones Stock Is Cheaper, Amgen or Merck?",
      "id": 133508616,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "AMGN",
      "source": "Yahoo",
      "summary": "Within that group, biotechnology giant Amgen (NASDAQ: AMGN) has been the best-performing stock in 2025, returning an impressive 21% year to date.  Meanwhile, shares of its pharmaceutical rival Merck (NYSE: MRK) have lagged, down 8% in the same period.  Amgen shareholders are celebrating, but have you wondered which stock is cheaper right now?",
      "url": "https://finnhub.io/api/news?id=2098633fa61e26ac514cdfd5c24d0756e5917dc5dbeb8609a8a0266e0f23e750"
    }
  }
]